Carrie S. Cox

Carrie S. Cox became a Director at Cardinal Health in 2009. Ms. Cox has also been a member of the Board of Directors at Organon & Co. since 2021, Selecta Biosciences, Inc. since 2019, Texas Instrument Incorporation since 2004, and Chairman of the Board at Candel Therapeutics since 2021. Ms. Cox was previously a Director at ElectroCore, Inc. from 2018 to 2020, a Director at Array BioPharma from 2018 to 2019 and Director at Celegne Corporation from 2009 to 2019. From 2018 to 2019, Ms. Cox served as the Executive Chairman of the Board at Humuacyte, Inc. and she was the Chairman and Chief Executive Officer from 2010 to 2018. Ms. Cox served as the Executive Vice President and President of Global Pharmaceuticals at Schering-Plough Corporation from 2003 to 2009 and Executive Vice President and President of Global Prescription Business at Pharmacia from 1997 to 2003.